Cohance Lifesciences Limited (BOM:543064)
India · Delayed Price · Currency is INR 462.60
-12.95 (-2.72%)
At close: Aug 21, 2026
Cohance Lifesciences Market Cap
Cohance Lifesciences has a market cap or net worth of 177.13 billion as of August 21, 2026. Its market cap has decreased by -48.25% in one year.
Market Cap
177.13B
Enterprise Value
179.10B
Revenue
21.42B
Ranking
n/a
PE Ratio
166.74
Stock Price
462.60
ChartMarket Cap Chart
Since March 9, 2020, Cohance Lifesciences's market cap has increased from 33.71M to 177.13B, an increase of 525,426.14%. That is a compound annual growth rate of 277.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 177.13B | -12.41% |
| Dec 31, 2025 | 202.22B | -30.24% |
| Dec 31, 2024 | 289.89B | 57.55% |
| Dec 29, 2023 | 184.00B | 46.05% |
| Dec 30, 2022 | 125.98B | 0.33% |
| Dec 31, 2021 | 125.56B | 9.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GlaxoSmithKline Pharmaceuticals | 491.21B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Rubicon Research | 285.49B |
| Granules India | 212.72B |
| Caplin Point Laboratories | 194.45B |
| AstraZeneca Pharma India | 185.26B |
| Jubilant Pharmova | 139.25B |
| CORONA Remedies | 131.04B |